Higher values of hepatic lipase activity in postmenopause: Relationship with atherogenic intermediate density and low density lipoproteins

Menopause

Volumn 8, Issue 1, 2001, Pages 51-57

  Berg, Gabriela A ^a   Siseles, Néstor ^a   González, Ana I ^a   Ortiz, Oscar Contreras ^a   Tempone, Antonio ^a   Wikinski, Regina W ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

HDL; Hepatic lipase; IDL; LDL; Postmenopause

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LIVER TRIACYLGLYCEROL LIPASE; LOW DENSITY LIPOPROTEIN;

ADULT; AMENORRHEA; ARTICLE; ATHEROGENESIS; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME ANALYSIS; FATTY ACID BLOOD LEVEL; FEMALE; HORMONAL THERAPY; HUMAN; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; POSTMENOPAUSE;

EID: 0035154886     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042192-200101000-00009     Document Type: Article

References (33)

1. Cardiovascular disease in women
2. Increased risk of atherosclerosis in women after the menopause
3. Early menopause and the risk of myocardial infraction
4. Hypercholesterolemia in postmenopausal women
5. Effects of oestradiol and levonorgestrel on lipoprotein lipids and post-heparin plasma lipase activities in normolipoproteinemic women
6. 2 cholesterol
7. Oral estrogen replacement therapy in postmenopausal women selectively raises levels and production rates of lipoprotein A-I and lowers hepatic lipase activity without lowering the fractional catabolic rate
8. Lipoprotein metabolism in postmenopausal and oophorectomized women
9. Small low-density lipoprotein particles in women with natural or surgically induced menopause
10. Effect of hepatic lipase on LDL in normal men and those with coronary artery disease
11. LDL (low-density-lipoprotein) cholesterol determination in blood serum following precipitation of LDL with poly(vinyl sulphate)
12. 2+ precipitation for quantitation of high-density lipoprotein cholesterol
13. Measurement and clinical significance of high density lipoprotein cholesterol: Subclasses
14. New method for isolating and quantifying intermediate and β-very low density lipoprotein cholesterol
15. Rapid, simple and specific assays for lipoprotein lipase and hepatic lipase
16. Evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel II)
17. Metabolic and genetic determinants of HDL metabolism and hepatic lipase activity in normolipidemic females
18. Role of hepatic triglyceride lipase activity in the association between intra-abdominal fat and plasma HDL cholesterol in obese women
19. A hepatic lipase gene promoter polymorphism attenuates the increase in hepatic lipase activity with increasing intra-abdominal fat in women
20. Intermediate density lipoprotein cholesterol as the best lipoprotein predictor of atherosclerosis severity in the Watanabe heritable hyperlipidemic rabbit
21. Intermediate-density lipoproteins and progression of carotid arterial wall intima-media thickness
22. Interaction of very-low-density, intermediate-density, and low-density lipoproteins with human arterial wall proteoglycans
23. Very low density lipoproteins and subclasses of intermediate density lipoproteins in postmenopausal women
24. Lipoprotein cholesterol distributions in selected North American populations: The lipid research clinics program prevalence study
25. The effect of menopause on blood lipid and lipoprotein levels
26. Does lipoprotein or hepatic lipase activity explain the protective lipoprotein profile of premenopausal women?
27. Transformation of high density, lipoprotein 2 particles by hepatic lipase and phospholipid transfer protein
28. Plasmatic apolipoproteins and lipidic composition of lipoproteins in pre and postmenopausal women
29. 2
30. Absence of association between genetic variation in the LIPC gene promoter and plasma lipoproteins in three Canadian populations
31. A major locus influencing plasma high-density lipoprotein cholesterol levels in the San Antonio Family Heart Study: Segregation and linkage analyses
32. Estrogen and lipid profile in patients with endometriosis treated by GnRH agonist
33. Endogenous estrogens: Relationship between estrone, estradiol, non-protein bound estradiol, and hot flashes and lipids